Table 3 Factors associated with the occurrence of major adverse cardiovascular events
| Â | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
Age | 1.06 (1.04–1.08) | <0.001 | 1.04 (1.02–1.06) | <0.001 |
Male sex | 1.27 (0.89–1.81) | 0.188 | NA | NA |
Body mass index | 0.99 (0.95–1.04) | 0.775 | NA | NA |
Hypertension | 2.33 (1.65–3.28) | <0.001 | 1.82 (1.28–2.61) | 0.001 |
CKD | 4.29 (2.68–6.86) | <0.001 | 2.71 (1.66–4.44) | <0.001 |
Smoking | 1.09 (0.73–1.63) | 0.667 | NA | NA |
Antiplatelet use | 1.53 (1.11–2.11) | 0.009 | NA | NA |
Statin use | 0.92 (0.67–1.26) | 0.589 | NA | NA |
Insulin use | 1.62 (1.08–2.43) | 0.019 | NA | NA |
HbA1c value | 1.22 (1.10–1.36) | <0.001 | 1.21 (1.08–1.35) | 0.001 |
Creatinine level | 1.24 (1.09–1.41) | 0.001 | NA | NA |
Group 1 | Reference | Â | Â | Â |
Group 2 | 1.52 (1.06–2.19) | 0.023 | 1.07 (0.74–1.56) | 0.712 |
Group 3 | 2.86 (1.59–5.15) | <0.001 | 1.93 (1.06–3.51) | 0.032 |
Group 4 | 4.11 (2.43–6.95) | <0.001 | 2.07 (1.17–3.66) | 0.012 |